The short version
4 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Isovue 370
Iopamidol · IOPAMIDOL 755 mg/mL · Injection, Solution · Intravascular · Bracco Diagnostics Inc
NDC 00270-1316-04 · 10 BOTTLE in 1 BOX / 125 mL in 1 BOTTLE · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- analysis
- BIPSO GmbHGermanyanalysis · manufacture
- Bracco Imaging SpaItalyapi manufacture
- Labor LS SE & Co. KGGermanyanalysis
- Patheon Italia S.p.AItalyanalysis · manufacture
- analysis · manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- NDA018735
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- 0 patents, 4 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| exclusivity | I-975 | Oct 10, 2028 |
| exclusivity | I-975 | Oct 10, 2028 |
| exclusivity | I-975 | Oct 10, 2028 |
| exclusivity | I-975 | Oct 10, 2028 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Iopamidol (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Bracco Diagnostics Inc | IOPAMIDOL 612 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Slate Run Pharmaceuticals, LLC | IOPAMIDOL 408 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Slate Run Pharmaceuticals, LLC | IOPAMIDOL 612 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Bracco Diagnostics Inc | IOPAMIDOL 755 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Bracco Diagnostics Inc | IOPAMIDOL 408 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Bracco Diagnostics Inc | IOPAMIDOL 612 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Bracco Diagnostics Inc | IOPAMIDOL 510 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Bracco Diagnostics Inc | IOPAMIDOL 408 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Bracco Diagnostics Inc | IOPAMIDOL 755 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Patheon Italia S.p.A. | IOPAMIDOL 408 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Patheon Italia S.p.A. | IOPAMIDOL 510 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Patheon Italia S.p.A. | IOPAMIDOL 612 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Patheon Italia S.p.A. | IOPAMIDOL 755 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Slate Run Pharmaceuticals, LLC | IOPAMIDOL 510 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Slate Run Pharmaceuticals, LLC | IOPAMIDOL 755 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Slate Run Pharmaceuticals | IOPAMIDOL 612 mg/mL | Jul 15, 2026 | Jul 29, 2026 |
| Slate Run Pharmaceuticals | IOPAMIDOL 408 mg/mL | Jul 15, 2026 | Jul 29, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Isovue 370 — NDC 00270-1316-04," retrieved September 3, 2026, https://drugdashboards.com/drug/00270131604.
Free to cite with attribution — see how the data is put together.